Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-anesthetic Esketamine for Postoperative Depression in Non-Cardiac Thoracic Surgery
ChiCTR2500107302Phase 4Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in major depressive disorder (MDD) and postoperative depression (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: 17-item Hamilton Depression Rating Scale score (primary). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)postoperative depression
Beyond the preview
Go deeper on ChiCTR2500107302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107302.